Actively Recruiting

Age: 18Years +
All Genders
ID05919511

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Led by Incyte Corporation · Updated on 2026-03-24

1500

Participants Needed

32

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a prospective observational study to collect information from adults who have recently undergone an allogeneic stem cell transplant (alloSCT) and are at risk of developing chronic graft-versus-host disease (cGVHD). The study aims to understand the overall burden and severity of cGVHD and explore related healthcare resource use and biological changes over time. Participants in this study are adults aged 18 years or older who had an alloSCT between 90 and 180 days before enrolling. This is a non-interventional study, meaning no treatments are given as part of the research. Instead, participants are observed and data is collected over a period of up to 36 months to monitor their condition and related biological markers. During the study, participants will complete assessment questionnaires either independently or with some assistance. Researchers will collect blood, serum, and saliva samples to analyze changes in proteomic, cytologic, and molecular profiles. The main outcomes measured include the diagnosis and severity of cGVHD, use of personal and healthcare resources, and biological changes related to the disease. The study lasts up to three years, with ongoing monitoring and data collection throughout this time.

CONDITIONS

Brief Title

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 218 years inclusive at the time of signing the informed consent form
  • Allogeneic stem cell transplant 90 to 180 days prior to enrollment
  • Able to understand and willing to provide informed consent
  • Willing and able to complete participant-assessment questionnaires alone or with minimal assistance
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 36 months

Participants are observed over time to monitor the development and severity of chronic graft-versus-host disease and associated changes.

Periodic visits for assessments and sample collections up to 36 months

Trial Site Locations

Total: 32 locations

1

University of Alabama Birmingham

Birmingham, Alabama, United States, 35294

Actively Recruiting

2

Mayo Clinic Arizona

Phoenix, Arizona, United States, 85054

Actively Recruiting

3

City of Hope

Duarte, California, United States, 91010

Actively Recruiting

4

USC Norris Comprehensive Cancer Center

Los Angeles, California, United States, 90033

Actively Recruiting

5

University of Colorado

Aurora, Colorado, United States, 80309

Actively Recruiting

6

Mayo Clinic Jacksonville

Jacksonville, Florida, United States, 32224

Actively Recruiting

7

AdventHealth Orlando

Orlando, Florida, United States, 32803

Actively Recruiting

8

Moffit Cancer Center

Orlando, Florida, United States, 33612

Actively Recruiting

9

Emory University

Atlanta, Georgia, United States, 30322

Actively Recruiting

10

Georgia Cancer Center

Augusta, Georgia, United States, 30912

Actively Recruiting

11

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

12

Rush University Medical Group

Chicago, Illinois, United States, 60612

Actively Recruiting

13

The University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

14

Loyola University Medical Center

Maywood, Illinois, United States, 60153

Actively Recruiting

15

The University of Kansas Clinical Research Center

Fairway, Kansas, United States, 66205

Actively Recruiting

16

Tulane Cancer Center

New Orleans, Louisiana, United States, 70112

Completed

17

University of Maryland Medical Center

Baltimore, Maryland, United States, 21201

Actively Recruiting

18

Massachusetts Cancer Research Center

Boston, Massachusetts, United States, 02114

Actively Recruiting

19

Corewell Health

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

20

Mayo Clinic Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

21

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08602

Actively Recruiting

22

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10021

Actively Recruiting

23

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27514

Actively Recruiting

24

Levine Cancer Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

25

The Ohio State University

Columbus, Ohio, United States, 43201

Actively Recruiting

26

Oregon Health Sciences University

Portland, Oregon, United States, 97239

Actively Recruiting

27

Geisinger Health Systems

Danville, Pennsylvania, United States, 17822

Actively Recruiting

28

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37212

Actively Recruiting

29

Texas Oncology-Baylor Charles A. Sammons Cancer Center

Dallas, Texas, United States, 75246

Actively Recruiting

30

University of Utah, Huntsman Cancer Institute

Salt Lake City, Utah, United States, 84112

Actively Recruiting

31

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States, 98109

Actively Recruiting

32

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

Loading map...

Research Team

I

Incyte Corporation Call Center (US)

I

Incyte Corporation Call Center (ex-US)

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase IIb Study of Axatilimab in Combination With Extracor...

Chronic Graft Versus Host Disease

Actively Recruiting

1 location

BPC2001 for Prevention of Acute Graft-Versus-Host Disease Fo...

Graft -Versus-host-disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here